Eli Lilly and Co (LLY)

LLY (NYSE:Drugs) EQUITY
$80.05
neg -1.50
-1.90%
Today's Range: 80.18 - 81.11 | LLY Avg Daily Volume: 5,714,600
Last Update: 09/04/15 - 12:31 PM EDT
Volume: 1,406,401
YTD Performance: 18.28%
Open: $80.50
Previous Close: $81.60
52 Week Range: $60.58 - $90.18
Oustanding Shares: 1,108,540,541
Market Cap: 90,689,701,659
6-Month Chart
TheStreet Ratings Grade for LLY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 7 7 5
Moderate Buy 0 0 1 1
Hold 5 5 4 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.83 1.83 1.71 1.95
Latest Dividend: 0.50
Latest Dividend Yield: 2.44%
Dividend Ex-Date: 08/12/15
Price Earnings Ratio: 42.39
Price Earnings Comparisons:
LLY Sector Avg. S&P 500
42.39 42.40 24.50
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
4.84% 27.20% 81.70%
GROWTH 12 Mo 3 Yr CAGR
Revenue -15.10 -0.19 -0.07
Net Income -49.00 -0.45 -0.18
EPS -48.50 -0.43 -0.17
Earnings for LLY:
EBITDA 4.71B
Revenue 19.62B
Average Earnings Estimates
Qtr (09/15) Qtr (12/15) FY (12/15) FY (12/16)
Average Estimate $0.75 $0.76 $3.27 $3.59
Number of Analysts 9 7 12 12
High Estimate $0.81 $0.82 $3.33 $3.91
Low Estimate $0.68 $0.68 $3.21 $3.31
Prior Year $0.66 $0.75 $2.78 $3.27
Growth Rate (Year over Year) 13.97% 0.76% 17.75% 9.78%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Today may be a good opportunity to exit some names.

Lilly Up Nicely, Merck Down Real Money Pro($)

Eli Lilly (LLY) is up 5% following positive top-line Jardiance results for diabetes. Meanwhile, Merck (MRK) is down 4% on competitive concerns.
Tech, telecom stocks lead major averages lower.
Don't make a learning week a gambling week.
Futures are mixed as quarterly results begin to obscure Greece.
Bullish
Jul 16, 2015 | 7:37 AM EDT
Shares of LLY now seen reaching $92, according to BMO Capital. Estimates also increased, given higher expectations for Sola. Market Per...
Bullish
Jun 26, 2015 | 7:16 AM EDT
LLY estimates were raised through 2016, Leerink Partners said. Have a more bullish outlook for the pipeline. Outperform rating and new ...
As health-care stocks rally, it's time for politicians to move on.
Bullish
Jun 25, 2015 | 7:20 AM EDT
LLY was upgraded from Neutral to Buy, Bank of America/Merrill Lynch said. $101 price target. Estimates also increased for several pipel...

Eli Lilly Is Beating Everyone Real Money Pro($)

LLY's chart shows stellar price moves on very strong turnover and great Relative Strength.

Columnist Conversations

Dave - When we look at more people leaving the work force than the number of jobs being added, it become pret...
We added back some puts we sold yesterday a bit earlier this am. BOUGHT SPY SEPT 192 PUT AT 4.04 BOUGHT DIA SE...
1. It was a good move tactically to cover yesterday's SPY short. 2. It will prove to be a bad move tactically ...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.